Efficacy News and Research

RSS
Insects can be used to test the efficiency of new drugs

Insects can be used to test the efficiency of new drugs

ASNM inaugral conference to discuss the latest in nanomedicine

ASNM inaugral conference to discuss the latest in nanomedicine

Opinion: Local drug production in developing countries; Obama's PEPFAR changes

Opinion: Local drug production in developing countries; Obama's PEPFAR changes

SoftScan clinical results from a breast cancer treatment monitoring study to be presented at IEEE International Conference

SoftScan clinical results from a breast cancer treatment monitoring study to be presented at IEEE International Conference

FDA notifies PDUFA action date for Cell Therapeutics' NDA for pixantrone

FDA notifies PDUFA action date for Cell Therapeutics' NDA for pixantrone

Nurses urge CDC to follow the recommendations for swine flu protection from the Institute of Medicine

Nurses urge CDC to follow the recommendations for swine flu protection from the Institute of Medicine

Spectrum's ZEVALIN expanded label receives FDA approval for treating non-Hodgkin’s Lymphoma

Spectrum's ZEVALIN expanded label receives FDA approval for treating non-Hodgkin’s Lymphoma

Clinical trial of Cerebroprotein Hydrolysate for Injection completes

Clinical trial of Cerebroprotein Hydrolysate for Injection completes

Novel SLE Responder Index as the primary endpoint in two Phase 3 clinical trials

Novel SLE Responder Index as the primary endpoint in two Phase 3 clinical trials

Shire receives FDA approval for INTUNIV extended release tablets

Shire receives FDA approval for INTUNIV extended release tablets

OSI Pharmaceuticals initiates two clinical trials with OSI-906 oral insulin-like growth factor-1 receptor inhibitor

OSI Pharmaceuticals initiates two clinical trials with OSI-906 oral insulin-like growth factor-1 receptor inhibitor

rPA anthrax vaccine and its Valortim anthrax anti-toxin program data presented

rPA anthrax vaccine and its Valortim anthrax anti-toxin program data presented

HTDS announces closure of Regulation D 504 offering

HTDS announces closure of Regulation D 504 offering

Results of Phase 2 rheumatoid arthritis clinical trial announced

Results of Phase 2 rheumatoid arthritis clinical trial announced

Phase I clinical trial data of GDC-0449 published in the New England Journal Of Medicine

Phase I clinical trial data of GDC-0449 published in the New England Journal Of Medicine

Ecological catalysts to get ibuprofen and naxopren from oil production

Ecological catalysts to get ibuprofen and naxopren from oil production

Ethical Alternative Products launches the OmniFlex joint support formula

Ethical Alternative Products launches the OmniFlex joint support formula

First-quarter fiscal 2010 results announced by Peregrine Pharmaceuticals

First-quarter fiscal 2010 results announced by Peregrine Pharmaceuticals

Medtronic's COPE-HCV clinical study commences

Medtronic's COPE-HCV clinical study commences

Uroplasty highlights the result of OrBIT trial of its Urgent PC System

Uroplasty highlights the result of OrBIT trial of its Urgent PC System

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.